Stocks and InvestingStocks and Investing
Thu, April 13, 2023
Wed, April 12, 2023
Tue, April 11, 2023

Ami Fadia Reiterated (BIIB) at Strong Buy and Held Target at $325 on, Apr 11th, 2023


Published on 2024-10-28 02:41:34 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Reiterated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $325 on, Apr 11th, 2023.

Ami has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 0 agree with Ami's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Ami


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Thursday, March 23rd, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $333 on, Thursday, February 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $310 on, Thursday, February 16th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $351 on, Thursday, February 16th, 2023
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023